Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Wullenkord R 

PROVIDER: S-EPMC7817557 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature